Back
SELLAS Life Sciences Group Vs. Galectin Therapeutics Industry Stock Comparison
Sell
47
SLS
SELLAS Life Sciences Group
Last Price:
1.17
Seasonality Move:
12%
Sell
46
GALT
Galectin Therapeutics
Last Price:
2.77
Seasonality Move:
36.71%
Sell
47
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy, Sell or Hold?
- The current SELLAS Life Sciences Group [SLS] share price is $1.17. The Score for SLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- SLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy, Sell or Hold?
- The current Galectin Therapeutics [GALT] share price is $2.78. The Score for GALT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- GALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLS Stock Price Chart
What is SELLAS Life Sciences Group's stock price today?
-
The SELLAS Life Sciences Group share price today is $1.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLS is experiencing selling pressure, which indicates risk of future bearish movement.
GALT Stock Price Chart
What is Galectin Therapeutics's stock price today?
-
The Galectin Therapeutics share price today is $2.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GALT is experiencing slight buying pressure.
SLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 42.81 | Sell |
| Chaikin Money Flow: | -689516 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.28) | Sell |
| Bollinger Bands (100): | (1.16 - 1.28) | Sell |
GALT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 53.13 | Buy |
| Chaikin Money Flow: | 57181 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.53 - 2.85) | Buy |
| Bollinger Bands (100): | (2.33 - 2.77) | Buy |
SLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.26 | Sell |
| 20-day SMA: | 1.23 | Sell |
| 50-day SMA: | 1.23 | Sell |
| 200-day SMA: | 1.23 | Sell |
| 8-day EMA: | 1.24 | Sell |
| 20-day EMA: | 1.24 | Sell |
| 50-day EMA: | 1.23 | Sell |
| 200-day EMA: | 1.25 | Sell |
GALT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.77 | Buy |
| 20-day SMA: | 2.72 | Buy |
| 50-day SMA: | 2.7 | Buy |
| 200-day SMA: | 2.6 | Buy |
| 8-day EMA: | 2.77 | Buy |
| 20-day EMA: | 2.74 | Buy |
| 50-day EMA: | 2.68 | Buy |
| 200-day EMA: | 2.51 | Buy |
SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.07 per share.
Galectin Therapeutics Earnings Growth & GALT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SELLAS Life Sciences Group Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Galectin Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||